September 27, 2007) - Gene Express, Inc. today announced that its molecular diagnostic test for lung cancer has demonstrated high levels of accuracy in a recent study presented at the American Association for Cancer Research's second International Conference on Molecular Diagnostics in Cancer Therapeutic Development... To determine which genes are active in lung cancer, Dr. Willey and his colleagues utilized Gene Express's proprietary and patented StaRT-PCR™ (Standardized Reverse Transcription Polymerase Chain Reaction) platform technology for measuring messenger RNA (mRNA) transcripts levels of the 15 genes... Gene Express' press Release -
Sep 28, 2007
Gene Express, Lung Cancer Diagnostic
September 27, 2007) - Gene Express, Inc. today announced that its molecular diagnostic test for lung cancer has demonstrated high levels of accuracy in a recent study presented at the American Association for Cancer Research's second International Conference on Molecular Diagnostics in Cancer Therapeutic Development... To determine which genes are active in lung cancer, Dr. Willey and his colleagues utilized Gene Express's proprietary and patented StaRT-PCR™ (Standardized Reverse Transcription Polymerase Chain Reaction) platform technology for measuring messenger RNA (mRNA) transcripts levels of the 15 genes... Gene Express' press Release -
